MIG
IONS icon

Mariner Investment Group’s Ionis Pharmaceuticals IONS Stock Holding History

Mariner Investment Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-28,820
Closed -$1.17M – 159
2016
Q1 		$1.17M Sell
28,820
-6,800
-19% -$276K 0.32% 89
2015
Q4 		$2.21M Sell
35,620
-16,380
-32% -$884K 0.49% 71
2015
Q3 		$2.1M Buy
+52,000
New +$2.69M 0.42% 73

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Mariner Investment Group's IONS Position: Q2 2016 in Review

Mariner Investment Group sold out of Ionis Pharmaceuticals (IONS) in Q2 2016, closing a stake of 28,820 shares — an estimated $1.17M sold.

Mariner Investment Group first reported a position in IONS in Q3 2015 and held it in 3 quarters. The position peaked at $2.21M in Q4 2015. 282 funds tracked by Wall St. Rank hold IONS as of Q2 2016.

  • Mariner Investment Group reported no remaining Ionis Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Mariner Investment Group sold 28,820 Ionis Pharmaceuticals shares in Q2 2016, an estimated $1.17M.
  • Mariner Investment Group first reported a position in Ionis Pharmaceuticals in Q3 2015 and held it in 3 quarters.
  • Mariner Investment Group's Ionis Pharmaceuticals position peaked at $2.21M in Q4 2015.
  • 282 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2016.

Based on Mariner Investment Group's 13F filing for Q2 2016, filed 3 Aug 2016.